{Reference Type}: Journal Article
{Title}: ABA supports AMA regarding monkeypox name change: A satire.
{Author}: Cohen PR;
{Journal}: Clin Dermatol
{Volume}: 40
{Issue}: 6
{Year}: Nov-Dec 2022
{Factor}: 2.797
{DOI}: 10.1016/j.clindermatol.2022.08.007
{Abstract}: The names of organizations, teams, and medical conditions can elicit controversy when presumedly unintentional defamation of a subset of individuals is perceived. Indeed, this has recently resulted in changing the names of sports teams and diseases. Previously, the ABA (American Baboon Association) solicited the other ABA (American Bar Association), and the drug reaction initially described to as baboon syndrome is now appropriately referred to as symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). Currently, the AMA (American Monkey Association)-with the support of the ABA (American Baboon Association) -has notified the other AMA (American Medical Association) that they consider the name monkeypox unacceptable for this viral infection. The ABA (American Baboon Association) and the AMA (American Monkey Association) are fictional organizations created by the author for the purpose of this satire.